Trending...
- Talaria E-bike China Source Cuts Talaria Sting MX5 Pro Pricing by $700 - 158
- Long Beach to Launch Time Capsule Honoring America's 250th Anniversary as Part of 908 Day Celebration
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
MOUNTAIN VIEW, Calif. - Californer -- Adaptic Health, a leading provider of clinical development software, today announced the launch of its new platform designed to streamline the clinical trial design process. Clinical trials are essential for advancing medical research and bringing new treatments to patients, but they can be complex and time-consuming and the existing tools available for clinical study protocol development have not kept up with the increasing complexity. With the advent of new challenges such as remote approaches, genetic advancements, and diverse patient populations, the need for a more efficient and effective approach to trial design has become increasingly pressing.
Adaptic Health's platform provides biopharma companies with a digital infrastructure for clinical development, starting with trial design. The platform empowers Chief Medical Officers (CMOs) and clinical teams with collaboration tools, a dynamic literature review, and what-if analysis capabilities, reducing the time and cost of clinical trial design by up to six months and saving millions of dollars.
"We are thrilled to bring this innovative solution to the market, especially in the wake of the COVID-19 pandemic, which has highlighted the need for accelerated trial design and execution across any disease area," said Luke Stewart and co-founder, CEO of Adaptic Health. "Our platform streamlines collaboration and enables users to learn from the past, explore different design tradeoffs, and accelerate protocol approval, all in one convenient and powerful platform."
More on The Californer
Adaptic Health's platform leverages previous experience to help CMOs and clinical teams improve the chances of success in their clinical trials. The platform consolidates historic FDA decisions and real-world data, providing a comprehensive resource for understanding the regulatory landscape and making informed decisions about trial design. Additionally, the platform's simulation tools allow users to explore different design tradeoffs and scenarios, such as the impact of different sample sizes or endpoint definitions, and see how they might affect the outcomes of the trial.
"The ability to simulate design tradeoffs is crucial for CMOs and other decision-makers who need to make informed choices about the direction and focus of their clinical trial development program," said Charles Barr, Chief Medical Officer and co-founder of Adaptic Health. "Our platform provides a powerful and convenient way to access and analyze data, making it easier for users to make informed decisions and optimize their trial design."
"Clinical trial design is a creative process. As such, inspiration is key. Adaptic Health brings the past into view so you can create the best future for your development program," said Stanley Lewis, CEO of A28 Therapeutics. "You also get faster stakeholder buy-in of your plan through the collaborative trial summary. By bringing this element into focus early, Adaptic accelerates the journey to clinical trial success."
More on The Californer
Visit us on our website at https://www.adaptichealth.io or email us at sales@adaptichealth.io to learn how you can get early access to the platform, now available in beta. The platform is expected to be generally available in 6 months.
About Adaptic Health
Adaptic Health offers a powerful software as a service (SaaS) platform that helps organizations accelerate clinical development from the earliest stage of design through biostatistical optimization. Our platform streamlines collaboration, enables dynamic literature review, and provides what-if analysis tools, reducing the time and cost of clinical trial design by up to six months and saving millions of dollars.
Adaptic Health's platform provides biopharma companies with a digital infrastructure for clinical development, starting with trial design. The platform empowers Chief Medical Officers (CMOs) and clinical teams with collaboration tools, a dynamic literature review, and what-if analysis capabilities, reducing the time and cost of clinical trial design by up to six months and saving millions of dollars.
"We are thrilled to bring this innovative solution to the market, especially in the wake of the COVID-19 pandemic, which has highlighted the need for accelerated trial design and execution across any disease area," said Luke Stewart and co-founder, CEO of Adaptic Health. "Our platform streamlines collaboration and enables users to learn from the past, explore different design tradeoffs, and accelerate protocol approval, all in one convenient and powerful platform."
More on The Californer
- High Rise 6: Power to Escape Expands the Film Franchise With New Cartels, New Locations
- Impact & Influence Radio Welcomes Former San Francisco 49ers Player Alex Barrett
- Free National Summit Empowers Animal Advocacy
- Dodge Hornet Lemon Law Attorney in Los Angeles County
- 'Nightmare' Star Mckenna Bridger Talks Psychological Thriller, Two-Part Shoot And Taking On Violet Adams
Adaptic Health's platform leverages previous experience to help CMOs and clinical teams improve the chances of success in their clinical trials. The platform consolidates historic FDA decisions and real-world data, providing a comprehensive resource for understanding the regulatory landscape and making informed decisions about trial design. Additionally, the platform's simulation tools allow users to explore different design tradeoffs and scenarios, such as the impact of different sample sizes or endpoint definitions, and see how they might affect the outcomes of the trial.
"The ability to simulate design tradeoffs is crucial for CMOs and other decision-makers who need to make informed choices about the direction and focus of their clinical trial development program," said Charles Barr, Chief Medical Officer and co-founder of Adaptic Health. "Our platform provides a powerful and convenient way to access and analyze data, making it easier for users to make informed decisions and optimize their trial design."
"Clinical trial design is a creative process. As such, inspiration is key. Adaptic Health brings the past into view so you can create the best future for your development program," said Stanley Lewis, CEO of A28 Therapeutics. "You also get faster stakeholder buy-in of your plan through the collaborative trial summary. By bringing this element into focus early, Adaptic accelerates the journey to clinical trial success."
More on The Californer
- Mckenna Bridger on Becoming Violet Adams in Nightmare
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
- Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Jeff Stanescu Construction Leadership • Project Delivery • Dispute Resolution
Visit us on our website at https://www.adaptichealth.io or email us at sales@adaptichealth.io to learn how you can get early access to the platform, now available in beta. The platform is expected to be generally available in 6 months.
About Adaptic Health
Adaptic Health offers a powerful software as a service (SaaS) platform that helps organizations accelerate clinical development from the earliest stage of design through biostatistical optimization. Our platform streamlines collaboration, enables dynamic literature review, and provides what-if analysis tools, reducing the time and cost of clinical trial design by up to six months and saving millions of dollars.
Source: Adaptic Health
Filed Under: Health
0 Comments
Latest on The Californer
- Gateway Oaks Dental Marks 18th Year in Sacramento by Investing in Modern Dental Technology
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- AI Biological Weapon Concerns Increase Focus on CBRN Protection for Private Shelters
- Designer-Inspired Jewellery Gifts: Timeless Pieces for Every Occasion
- Build a Stronger Online Presence with Strategic Web Design & Development
- California: What they are saying: National leaders and lawmakers celebrate Governor Newsom's signature on landmark child safety chatbot and social media laws
- California: Governor Newsom announces appointments 9.10.26
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
- 80th Annual East Los Angeles Mexican Independence Day Parade and Festival
- Attn: ALL BUSINESSES: This very effective Marketing Math could help you increase your Sales & Profit
- Pervaziv AI Launches Cortex Cloud, Bringing Durable Managed Execution to Enterprise AI
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Long Beach Flood Water Damage Provides Local Water Damage Restoration Services to Long Beach, CA
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- DJ HOTMESS Road To Los Angeles Nightlife
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
- DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
- Angélica Dueñas Kicks Off 2026 General Election Campaign for CA's 29th Congressional District